Italia markets close in 2 hours

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
2,3700+0,0200 (+0,85%)
Al 09:30AM EST. Mercato aperto.

Bionano Genomics, Inc.

9540 Towne Centre Drive
Suite 100
San Diego, CA 92121
United States
858 888 7600
https://bionanogenomics.com

Settore/iHealthcare
SettoreDiagnostics & Research
Impiegati a tempo pieno147

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Dr. Robert Erik HolmlinPres, CEO, Sec. & Director519,07kN/D1968
Mr. Christopher P. StewartChief Financial Officer77,93kN/D1970
Mr. Mark OldakowskiChief Operating Officer376,1kN/D1974
Dr. Alka Chaubey FACMG, Ph.D.Chief Medical OfficerN/DN/D1973
Mr. Robert J. PriarChief Commercial OfficerN/DN/DN/D
Mr. Richard ShippyChief Bus. OfficerN/DN/DN/D
Dr. Soheil Shams Ph.D.Chief Informatics OfficerN/DN/DN/D
Mark AdamchakControllerN/DN/DN/D
Dr. Paul R. Selvin Ph.D.Scientific AdvisorN/DN/DN/D
Prof. Pui-Yan Kwok M.D., Ph.D.Scientific AdvisorN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Its Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. The company also provides diagnostic testing for those with autism spectrum disorder and other neurodevelopmental disabilities. In addition, it offers an agnostic cross-platform data interpretation and clinical reporting software that integrates next-generation sequencing and microarray data, and provides visualization of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome for a fully integrated analysis in one view. The company was founded in 2006 and is headquartered in San Diego, California.

Governance aziendale

L'ISS Governance QualityScore di Bionano Genomics, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.